Injective (INJ) Bounces Back: Investor Momentum Sparks 12% Rally
Summary
Injective's native token, INJ, surged over 12% in 24 hours due to a market rally and increased market cap. Utila announced support for Injective, citing its infrastructure and functionalities. INJ's chart indicates potential for long-term gains, but faces resistance at $18.02. Analysts warn of a possible short squeeze in the current rally.
